Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 19, Number 10—October 2013

Research

Plasmodium vivax Malaria during Pregnancy, Bolivia

Laurent Brutus, José Santalla, Dominique Schneider, Juan Carlos Avila, and Philippe Deloron
Author affiliations: Institut de Recherche pour le Développement, Paris, France (L. Brutus, D. Schneider, P. Deloron); Université Paris Descartes, Paris (L. Brutus, D. Schneider, P. Deloron); Ministerio de Salud y Deportes, La Paz, Bolivia (J. Santalla); Vector-borne Diseases Program, Guayaramerín, Beni, Bolivia (J.C. Avila)

Main Article

Table 2

Risks for low birthweight and maternal anemia associated with placental Plasmodium vivax infections, Guayaramerín and Bermejo, Bolivia, 2002–2004*

Risk OR for adverse condition (95% CI), p value
Adjusted OR† (95% CI), p value
Bermejo Guayaramerín
Low-birthweight babies of women with or without placental infection 3.4 (0.7–16.1), 0.10 3.7 (1.2–11.2), 0.01 3.6 (1.4–8.9), 0.003
Moderate-to-severe anemia among women with or without placental infection 4.3 (1.1–16.4), 0.02 1.8 (0.5–6.1) 0.35 2.5 (1.0–6.2), 0.03

*OR, odds ratio. Significant values (p<0.05) are indicated in boldface.
†Adjusted OR after stratifying for study sites.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO